| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.66B | 1.55B | 1.43B | 1.25B | 1.03B | 666.20M |
| Gross Profit | 790.90M | 772.70M | 493.70M | 611.90M | 495.40M | 321.60M |
| EBITDA | 249.30M | 222.20M | 197.40M | 183.40M | 75.10M | 99.70M |
| Net Income | -27.30M | -59.40M | -85.60M | -16.60M | -160.40M | -157.10M |
Balance Sheet | ||||||
| Total Assets | 3.47B | 3.38B | 3.29B | 3.38B | 2.84B | 2.57B |
| Cash, Cash Equivalents and Short-Term Investments | 62.10M | 79.50M | 39.00M | 110.50M | 141.80M | 101.50M |
| Total Debt | 1.40B | 1.37B | 1.35B | 1.37B | 1.15B | 1.65B |
| Total Liabilities | 1.70B | 1.61B | 1.55B | 1.59B | 1.32B | 1.99B |
| Stockholders Equity | 1.77B | 1.77B | 1.74B | 1.79B | 1.51B | 584.00M |
Cash Flow | ||||||
| Free Cash Flow | 177.00M | 147.10M | 123.80M | 106.00M | 36.80M | -52.40M |
| Operating Cash Flow | 234.90M | 194.20M | 153.40M | 138.60M | 55.10M | -35.20M |
| Investing Cash Flow | -252.60M | -170.80M | -172.10M | -419.80M | -262.90M | -151.30M |
| Financing Cash Flow | 7.70M | 16.50M | -52.30M | 247.50M | 248.10M | 202.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | C$1.87B | 20.69 | 65.57% | 2.28% | 11.59% | 41.99% | |
71 Outperform | $285.00M | 2.23 | 39.85% | 2.35% | -40.05% | 558.77% | |
63 Neutral | C$2.01B | 47.69 | 7.07% | 4.47% | 11.47% | 6.45% | |
63 Neutral | C$2.19B | -78.40 | -1.56% | 0.68% | 10.09% | 67.54% | |
59 Neutral | C$244.01M | 3,890.00 | 0.11% | 1.03% | 0.19% | ― | |
58 Neutral | C$1.07B | -24.06 | -5.11% | ― | 26.20% | -156.86% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
Dentalcorp Holdings has secured approval under the Investment Canada Act for its previously announced acquisition by investment funds affiliated with U.S. private equity firm GTCR, clearing a key regulatory hurdle for the transaction. Under the deal, GTCR’s acquisition vehicle will purchase all outstanding Dentalcorp shares, except those rolled over by founder and CEO Graham Rosenberg, President and CFO Nate Tchaplia and certain partner dentists, for C$11.00 per share in cash, with closing expected on or about January 14, 2026, subject to customary conditions. The move will shift Canada’s largest dental practice network into private ownership under GTCR, potentially giving the company greater financial flexibility and strategic backing to pursue expansion and operational initiatives alongside aligned management and partner dentists who are retaining a stake.
The most recent analyst rating on (TSE:DNTL) stock is a Hold with a C$11.50 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.
Dentalcorp Holdings Ltd. has received final court approval for its acquisition by investment funds affiliated with GTCR LLC. The transaction involves GTCR acquiring all of Dentalcorp’s shares, except for those owned by certain key stakeholders, at C$11.00 per share. This acquisition, pending customary conditions and regulatory approvals, is expected to close in the first quarter of 2026. This move is poised to impact Dentalcorp’s operations by aligning with GTCR’s strategic goals, potentially influencing its market positioning and stakeholder interests.
The most recent analyst rating on (TSE:DNTL) stock is a Hold with a C$12.00 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.
Dentalcorp Holdings Ltd. announced that its securityholders have approved the acquisition by investment funds affiliated with GTCR LLC. This acquisition, valued at C$11.00 per share, is expected to provide Dentalcorp with enhanced flexibility to execute its long-term strategy, invest in technology and professional development, and expand its network of dental practices. The transaction reinforces Dentalcorp’s position as a leading partner for dental practices and is anticipated to close in the first quarter of 2026, pending customary conditions and regulatory approvals.
The most recent analyst rating on (TSE:DNTL) stock is a Hold with a C$11.00 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.
Dentalcorp Holdings has announced that proxy advisory firms ISS and Glass Lewis recommend shareholders vote in favor of a proposed arrangement where GTCR LLC will acquire all of Dentalcorp’s voting shares for $11.00 per share in cash. This transaction, which excludes shares owned by key executives and partner dentists participating in a rollover opportunity, is supported by the company’s board and a special committee, highlighting its fairness and alignment with the company’s best interests.
The most recent analyst rating on (TSE:DNTL) stock is a Hold with a C$11.00 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.
Dentalcorp Holdings reported a strong financial performance in the third quarter of 2025, with revenue increasing by 11.9% to $420.1 million and adjusted EBITDA rising by 14.2% compared to the previous year. The company expanded its operations by acquiring 13 new practice locations, contributing to a total of 590 locations, and achieved a high recurring patient visit rate of 90.3%. Additionally, Dentalcorp announced an arrangement agreement to be acquired by funds affiliated with GTCR LLC in an all-cash transaction valued at approximately $2.2 billion on an equity value basis. This acquisition, offering a 33% premium on the share price, signifies a significant shift in the company’s ownership structure and market positioning.
The most recent analyst rating on (TSE:DNTL) stock is a Hold with a C$11.50 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.
Dentalcorp Holdings Ltd. has received an interim order from the Supreme Court of British Columbia for a special meeting regarding its acquisition by GTCR-affiliated funds. The arrangement involves a cash offer of C$11.00 per share, a 33% premium on the 20-day VWAP. L Catterton Investor will receive cash for its shares, aligning with other shareholders, and has amended its voting support agreement to favor the acquisition. The transaction has significant backing from key stakeholders, representing a 60.8% voting interest, and the Board recommends approval.
The most recent analyst rating on (TSE:DNTL) stock is a Hold with a C$11.50 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.